{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:22:18Z","timestamp":1781954538170,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04268-3","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:33:48Z","timestamp":1765715628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of drug candidate to inhibit bronchogenic carcinoma genes biomarkers based on drug repurposing"],"prefix":"10.1007","volume":"17","author":[{"given":"Bagher","family":"Khalvati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Behmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hosein","family":"Keyhanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Arabfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"4268_CR1","unstructured":"American Cancer Society IArr, including the right to reproduce this publication or portions thereof in any form. Email the American Cancer Society Legal department at permissionrequest@cancer.org for permission. Cancer Facts & Figs. 2025. 2025."},{"issue":"7","key":"4268_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346.","journal-title":"Int J Cancer"},{"key":"4268_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"4268_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"4268_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010049","volume":"15","author":"Y Chang","year":"2023","unstructured":"Chang Y, Hawkins BA, Du JJ, Groundwater PW, Hibbs DE, Lai F. A guide to in silico drug design. Pharmaceutics. 2023;15(1):49.","journal-title":"Pharmaceutics"},{"key":"4268_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104851","volume":"137","author":"B Shaker","year":"2021","unstructured":"Shaker B, Ahmad S, Lee J, Jung C, Na D. In silico methods and tools for drug discovery. Comput Biol Med. 2021;137:104851.","journal-title":"Comput Biol Med"},{"key":"4268_CR7","doi-asserted-by":"crossref","unstructured":"Kliegman M, Zaghlula M, Abrahamson S, Esensten JH, Wilson RC, Urnov FD, Doudna JA. A roadmap for affordable genetic medicines. Nature. 2024 Oct 10;634(8033):307-14.","DOI":"10.1038\/s41586-024-07800-7"},{"issue":"9","key":"4268_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA. 2020;323(9):844\u201353.","journal-title":"JAMA"},{"issue":"2","key":"4268_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20(2):273\u201386.","journal-title":"Biostatistics"},{"key":"4268_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&d costs. J Health Econ. 2016;47:20\u201333.","journal-title":"J Health Econ"},{"key":"4268_CR11","first-page":"151","volume":"22","author":"D Ja","year":"2002","unstructured":"Ja D. The price of innovation: new estimates of drug development costs. J Health Econ. 2002;22:151.","journal-title":"J Health Econ"},{"key":"4268_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709856","volume":"12","author":"DP Smith","year":"2021","unstructured":"Smith DP, Oechsle O, Rawling MJ, Savory E, Lacoste AM, Richardson PJ. Expert-augmented computational drug repurposing identified baricitinib as a treatment for COVID-19. Front Pharmacol. 2021;12:709856.","journal-title":"Front Pharmacol"},{"key":"4268_CR13","doi-asserted-by":"crossref","unstructured":"Drayman N, Jones KA, Azizi S-A, Froggatt HM, Tan K, Maltseva NI, et al. Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro. bioRxiv. 2020:2020.08.31.274639.","DOI":"10.1101\/2020.08.31.274639"},{"key":"4268_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.19.00001","volume":"3","author":"Y Wu","year":"2019","unstructured":"Wu Y, Warner JL, Wang L, Jiang M, Xu J, Chen Q, et al. Discovery of noncancer drug effects on survival in electronic health records of patients with cancer: a new paradigm for drug repurposing. JCO Clin Cancer Inform. 2019;3:1\u20139.","journal-title":"JCO Clin Cancer Inform"},{"issue":"8","key":"4268_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","volume":"20","author":"J Langedijk","year":"2015","unstructured":"Langedijk J, Mantel-Teeuwisse AK, Slijkerman DS, Schutjens M-HD. Drug repositioning and repurposing: terminology and definitions in literature. Drug Discov Today. 2015;20(8):1027\u201334.","journal-title":"Drug Discov Today"},{"issue":"4","key":"4268_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/d41573-023-00017-9","volume":"22","author":"K Nawaz","year":"2023","unstructured":"Nawaz K, Webster RM. The non-small-cell lung cancer drug market. Nat Rev Drug Discov. 2023;22(4):264\u20135.","journal-title":"Nat Rev Drug Discov"},{"key":"4268_CR17","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2018.886","volume":"12","author":"P Pantziarka","year":"2018","unstructured":"Pantziarka P, Verbaanderd C, Sukhatme V, Capistrano IR, Crispino S, Gyawali B, et al. ReDO_DB: the repurposing drugs in oncology database. ecancermedicalscience. 2018;12:886.","journal-title":"ecancermedicalscience"},{"issue":"3","key":"4268_CR18","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4268_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2020.11.012","volume":"19","author":"GD Novack","year":"2020","unstructured":"Novack GD. Repurposing medications. Ocul Surf. 2020;19:336.","journal-title":"Ocul Surf"},{"issue":"1","key":"4268_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02395-5","volume":"16","author":"B Khalvati","year":"2025","unstructured":"Khalvati B, Kavousi K, Keyhanipour AH, Arabfard M. Identifying candidate biomarkers for detecting bronchogenic carcinoma stages using metaheuristic algorithms based on information fusion theory. Discov Oncol. 2025;16(1):632.","journal-title":"Discov Oncol"},{"issue":"6","key":"4268_CR21","doi-asserted-by":"publisher","first-page":"e0233112","DOI":"10.1371\/journal.pone.0233112","volume":"15","author":"B Li","year":"2020","unstructured":"Li B, Dai C, Wang L, Deng H, Li Y, Guan Z, et al. A novel drug repurposing approach for non-small cell lung cancer using deep learning. PLoS One. 2020;15(6):e0233112.","journal-title":"PLoS One"},{"issue":"6","key":"4268_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1542\/peds.79.6.1032","volume":"79","author":"AK Shapiro","year":"1987","unstructured":"Shapiro AK, Shapiro E, Fulop G. Pimozide treatment of tic and Tourette disorders. Pediatrics. 1987;79(6):1032\u20139.","journal-title":"Pediatrics"},{"key":"4268_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.741326","volume":"11","author":"AS Jain","year":"2021","unstructured":"Jain AS, Prasad A, Pradeep S, Dharmashekar C, Achar RR, Silina E, et al. Everything old is new again: drug repurposing approach for non-small cell lung cancer targeting MAPK signaling pathway. Front Oncol. 2021;11:741326.","journal-title":"Front Oncol"},{"key":"4268_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109744","volume":"187","author":"A Sultana","year":"2025","unstructured":"Sultana A, Alam MS, Khanam A, Liang H. Unraveling the molecular landscape of non-small cell lung cancer: integrating bioinformatics and statistical approaches to identify biomarkers and drug repurposing. Comput Biol Med. 2025;187:109744.","journal-title":"Comput Biol Med"},{"key":"4268_CR25","unstructured":"Ioannidis VN, Song X, Manchanda S, Li M, Pan X, Zheng D, Ning X, Zeng X, Karypis G. Drkg-drug repurposing knowledge graph for covid-19. arXiv preprint arXiv:201009600. 2020."},{"issue":"2","key":"4268_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.55730\/1300-0152.2687","volume":"48","author":"TG Inci","year":"2024","unstructured":"Inci TG, Acar S, Balik D. Non-small cell lung cancer treatment: current status of drug repurposing and Nanoparticle-based drug delivery systems. Turk J Biol. 2024;48(2):112\u201332.","journal-title":"Turk J Biol"},{"issue":"5","key":"4268_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00432-020-03166-1","volume":"146","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wu S, Shi X, Liang Z, Zeng X. ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm. J Cancer Res Clin Oncol. 2020;146(5):1307\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4268_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117118","volume":"177","author":"Q-q Fan","year":"2024","unstructured":"Fan Q-q, Tian H, Cheng J-x, Zou J-b, Luan F, Qiao J-x, et al. Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: an update. Biomed Pharmacother. 2024;177:117118.","journal-title":"Biomed Pharmacother"},{"key":"4268_CR29","first-page":"1","volume-title":"The discovery and development of Viagra\u00ae(sildenafil citrate)","author":"IH Osterloh","year":"2004","unstructured":"Osterloh IH. The discovery and development of Viagra\u00ae(sildenafil citrate). Sildenafil: Springer; 2004. pp. 1\u201313."},{"issue":"4","key":"4268_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0738-081X(88)90078-8","volume":"6","author":"GR Zins","year":"1988","unstructured":"Zins GR. The history of the development of minoxidil. Clin Dermatol. 1988;6(4):132\u201347.","journal-title":"Clin Dermatol"},{"issue":"12","key":"4268_CR31","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/WNL.35.12.1772","volume":"35","author":"P Duquette","year":"1985","unstructured":"Duquette P, Pleines J, du Souich P. Isoniazid for tremor in multiple sclerosis: a controlled trial. Neurology. 1985;35(12):1772.","journal-title":"Neurology"},{"issue":"11","key":"4268_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2024.130706","volume":"1868","author":"A Wu","year":"2024","unstructured":"Wu A, Yang H, Xiao T, Gu W, Li H, Chen P. COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma. Biochim Biophys Acta BBA Gen Sub. 2024;1868(11): 130706.","journal-title":"Biochim Biophys Acta BBA Gen Sub"},{"key":"4268_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymeth.2021.08.001","volume":"198","author":"X-Y Li","year":"2022","unstructured":"Li X-Y, Xiang J, Wu F-X, Li M. NetAUC: a network-based multi-biomarker identification method by AUC optimization. Methods. 2022;198:56\u201364.","journal-title":"Methods"},{"key":"4268_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129332","volume":"260","author":"H Yang","year":"2024","unstructured":"Yang H, Zhou H, Fu M, Xu H, Huang H, Zhong M, et al. TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Macromol. 2024;260:129332.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4268_CR35","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e3","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, Yu Q, Xiao J, Chen Q, Fang M, Zhao H. Cigarette smoke extract-treated mouse airway epithelial cells-derived exosomal LncRNA MEG3 promotes M1 macrophage polarization and pyroptosis in chronic obstructive pulmonary disease by upregulating TREM-1 via m6A methylation. Immune Netw. 2024;24(2):e3.","journal-title":"Immune Netw"},{"key":"4268_CR36","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S499403","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen W, Zhou J, Liang Q, Zhang Y, Su M, et al. The benefits and safety of monoclonal antibodies: implications for cancer immunotherapy. J Inflamm Res. 2025. https:\/\/doi.org\/10.2147\/JIR.S499403.","journal-title":"J Inflamm Res"},{"key":"4268_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/0113892037362037250205143911","author":"R Fatima","year":"2025","unstructured":"Fatima R, Khan Y, Maqbool M, Ramalingam PS, Khan MG, Bisht AS, et al. Amyloid-\u03b2 clearance with monoclonal antibodies: transforming Alzheimer\u2019s treatment. Curr Protein Pept Sci. 2025. https:\/\/doi.org\/10.2174\/0113892037362037250205143911.","journal-title":"Curr Protein Pept Sci"},{"key":"4268_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.omtn.2020.07.003","volume":"21","author":"C Liu","year":"2020","unstructured":"Liu C, Wei D, Xiang J, Ren F, Huang L, Lang J, et al. An improved anticancer drug-response prediction based on an ensemble method integrating matrix completion and ridge regression. Mol Ther Nucleic Acids. 2020;21:676\u201386.","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04268-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:05:10Z","timestamp":1768914310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04268-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4268"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04268-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}